Increase/Decrease in Cash: The total change in cash for the company over the given period.
GlycoMimetics, Inc. (GLYC) had Increase/Decrease in Cash of $-31.07M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-37.88M |
|
-- |
|
-- |
|
$40.04M |
|
$-40.04M |
|
$2.16M |
|
$-37.88M |
|
$-39.10M |
|
$-37.88M |
|
$-37.88M |
|
$-37.88M |
|
$-39.10M |
|
$-40.04M |
|
$-40.00M |
|
64.48M |
|
64.48M |
|
$-0.59 |
|
$-0.59 |
|
| Balance Sheet Financials | |
$11.09M |
|
-- |
|
-- |
|
$11.09M |
|
$5.78M |
|
-- |
|
-- |
|
$5.78M |
|
$5.31M |
|
$5.31M |
|
$5.31M |
|
64.48M |
|
| Cash Flow Statement Financials | |
$-31.10M |
|
$0.02M |
|
$0.01M |
|
$41.79M |
|
$10.72M |
|
|
Increase/Decrease in Cash |
$-31.07M |
$4.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.92 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-31.08M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-712.88% |
|
-712.88% |
|
-341.52% |
|
-712.88% |
|
$0.08 |
|
$-0.48 |
|
$-0.48 |
|